Wellington Management Group
CRL icon

Wellington Management Group’s Charles River Laboratories CRL Stock Holding History

Wellington Management Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$292M Sell
1,288,463
-340,938
-21% -$60.7M 0.05% 313
2026
Q1 		$281M Sell
1,629,401
-119,812
-7% -$22.2M 0.05% 300
2025
Q4 		$349M Sell
1,749,213
-1,441,254
-45% -$261M 0.06% 267
2025
Q3 		$499M Sell
3,190,467
-577,338
-15% -$91.7M 0.09% 205
2025
Q2 		$572M Sell
3,767,805
-517,207
-12% -$69M 0.1% 180
2025
Q1 		$645M Buy
4,285,012
+208,586
+5% +$35M 0.12% 159
2024
Q4 		$753M Buy
4,076,426
+335,658
+9% +$64.7M 0.14% 151
2024
Q3 		$737M Buy
3,740,768
+3,738,018
+135,928% +$777M 0.13% 157
2024
Q2 		$568K Buy
2,750
+227
+9% +$51.4K ﹤0.01% 1769
2024
Q1 		$684K Sell
2,523
-193
-7% -$46.1K ﹤0.01% 1765
2023
Q4 		$642K Buy
+2,716
New +$534K ﹤0.01% 1697
2023
Q1 		– Sell
-210,650
Closed -$45.9M – 2016
2022
Q4 		$45.9M Buy
210,650
+24
+0% +$5.24K 0.01% 710
2022
Q3 		$41.5M Buy
+210,626
New +$45.5M 0.01% 716
2017
Q2 		– Sell
-806,753
Closed -$72.6M – 2217
2017
Q1 		$72.6M Sell
806,753
-30,120
-4% -$2.56M 0.02% 607
2016
Q4 		$63.8M Sell
836,873
-517
-0.1% -$39.3K 0.02% 641
2016
Q3 		$69.8M Sell
837,390
-43,604
-5% -$3.66M 0.02% 600
2016
Q2 		$72.6M Sell
880,994
-157,466
-15% -$13M 0.02% 563
2016
Q1 		$78.9M Sell
1,038,460
-41,319
-4% -$3.06M 0.02% 536
2015
Q4 		$86.8M Sell
1,079,779
-30,603
-3% -$2.21M 0.02% 508
2015
Q3 		$70.5M Sell
1,110,382
-203,310
-15% -$14.6M 0.02% 562
2015
Q2 		$92.4M Sell
1,313,692
-725,539
-36% -$53.7M 0.02% 512
2015
Q1 		$162M Sell
2,039,231
-1,123,483
-36% -$82.9M 0.04% 380
2014
Q4 		$201M Sell
3,162,714
-264,673
-8% -$16.6M 0.05% 336
2014
Q3 		$205M Sell
3,427,387
-6,131
-0.2% -$351K 0.06% 321
2014
Q2 		$184M Buy
3,433,518
+861,840
+34% +$47.3M 0.05% 379
2014
Q1 		$155M Sell
2,571,678
-68,102
-3% -$3.97M 0.04% 415
2013
Q4 		$140M Buy
2,639,780
+245,180
+10% +$12.3M 0.04% 425
2013
Q3 		$111M Buy
2,394,600
+203,041
+9% +$9.32M 0.03% 468
2013
Q2 		$89.9M Buy
+2,191,559
New +$93.9M 0.03% 502

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Wellington Management Group's CRL Position: Q2 2026 in Review

Wellington Management Group reduced its Charles River Laboratories (CRL) stake by 21% in Q2 2026, selling an estimated $60.7M and leaving 1,288,463 shares worth $292M. The position accounts for 0.05% of the portfolio, ranked #313.

Wellington Management Group first reported a position in CRL in Q2 2013 and has held it in 29 quarters since. The position peaked at $753M in Q4 2024. 568 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Wellington Management Group held 1,288,463 shares of Charles River Laboratories worth $292M as of Q2 2026.
  • Wellington Management Group sold 340,938 Charles River Laboratories shares in Q2 2026, an estimated $60.7M.
  • Charles River Laboratories made up 0.05% of Wellington Management Group's portfolio in Q2 2026, its #313 holding.
  • Wellington Management Group first reported a position in Charles River Laboratories in Q2 2013 and has held it in 29 quarters since.
  • Wellington Management Group's Charles River Laboratories position peaked at $753M in Q4 2024.
  • 568 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.